Casodex en es it fr

Casodex Brand names, Casodex Analogs

Casodex Brand Names Mixture

  • No information avaliable

Casodex Chemical_Formula


Casodex RX_link

Casodex fda sheet

Casodex FDA

Casodex msds (material safety sheet)

Casodex MSDS

Casodex Synthesis Reference

No information avaliable

Casodex Molecular Weight

430.374 g/mol

Casodex Melting Point

191-193 oC

Casodex H2O Solubility

5 mg/L

Casodex State


Casodex LogP


Casodex Dosage Forms


Casodex Indication

For treatment (together with surgery or LHRH analogue) of advanced prostatic cancer.

Casodex Pharmacology

Bicalutamide is an antineoplastic hormonal agent primarily used in the treatment of prostate cancer. Bicalutamide is a pure, nonsteroidal anti-androgen with affinity for androgen receptors (but not for progestogen, estrogen, or glucocorticoid receptors). Consequently, Bicalutamide blocks the action of androgens of adrenal and testicular origin which stimulate the growth of normal and malignant prostatic tissue. Prostate cancer is mostly androgen-dependent and can be treated with surgical or chemical castration. To date, antiandrogen monotherapy has not consistently been shown to be equivalent to castration.

Casodex Absorption

Bicalutamide is well-absorbed following oral administration, although the absolute bioavailability is unknown.

Casodex side effects and Toxicity

No information avaliable

Casodex Patient Information

Patients should be informed that therapy with CASODEX and the LHRH analogue should be initiated concomitantly, and that they should not interrupt or stop taking these medications without consulting their physician. Treatment with CASODEX should be started at the same time as treatment with an LHRH analogue.

Casodex Organisms Affected

Humans and other mammals